Time to revisit your disaster plan?
11 March 2020 by CITI Program

COVID-19 dominates daily news headlines as communities and organizations evaluate policies regarding public gatherings, quarantines, and other issues. Many states, including New York and California,…

Research During Global Health Emergencies
9 March 2020 by CITI Program

Complying with research ethics is notably challenging during global health emergencies such as the outbreak of coronavirus disease (COVID-19). Investigators must have an ethical framework…

U.S. Federal Regulatory Agencies Provide Guidance for Clinical Trials in Response to COVID-19
24 March 2020 by CITI Program

As COVID-19 continues to impact research organizations and clinical sites, federal agencies are issuing guidance for clinical trials. Organizations are closing or dramatically reducing operations…

Compliance With Posting Clinical Trials Results on ClinicalTrials.gov
6 February 2020 by CITI Program

Both the journals Science and The Lancet have recently published studies showing a lack of compliance with posting clinical trials results on ClinicalTrials.gov. Be sure…

Ethical Considerations for Replicating Bones with 3D Printing
24 January 2020 by CITI Program

Evolving technology now makes 3D printing an inexpensive technology for reproducing replica bones. Digital bone repositories around the world are currently working through the ethical…

Webcast of NAS Workshop, An Examination of Emerging Bioethical Issues in Biomedical Research
23 January 2020 by CITI Program

The National Academy of Sciences, Engineering, and Medicine will be hosting An Examination of Emerging Bioethical Issues in Biomedical Research on February 26, 2020 at…

The Importance of Improving ClinicalTrials.gov Compliance
12 February 2020 by CITI Program

For two decades, the federal government has encouraged transparency in research. As a result of these efforts, it established ClinicalTrials.gov, a national registry of U.S….

Improving Drugs Through Patient-Centric Design for Clinical Trials
9 January 2020 by CITI Program

Read about the approach to drug development that includes tolerability, ease of use, compliance with therapy, and quality of life as topics addressed along with…

OHRP Releases the 2020 Edition of the International Compilation of Human Research Standards
10 March 2020 by CITI Program

View OHRP’s 2020 edition of the International Compilation of Human Research Standards. This compilation of laws, regulations, and guidelines is helpful to CITI Program organizations…

Resource to Determine if Your Research Involves Human Subjects
8 January 2020 by CITI Program

The NIH Office of Extramural Research (OER) provides a decision tool to help determine if research is considered human subjects research and if it may…

Guidance Issued on the Application of FERPA and HIPAA to Student Health Records
3 January 2020 by CITI Program

The U.S. Departments of Health and Human Services and Education have released “Joint Guidance on the Application of the Family Educational Rights and Privacy Act…

Revised Common Rule Now in Full Effect
22 January 2020 by CITI Program

On January 20, 2020, the sIRB requirement under the revised Common Rule went into effect. This marked the final step in the timeline for full…